The health ministry has issued mandatory safety standards for the $2.1 billion cosmetology market, requiring clinics to be run by qualified dermatologists or plastic surgeons. This move aims to eliminate unauthorized 'ghost clinics' but may increase operating costs and regulatory scrutiny for businesses in the aesthetic services space.
The Union health ministry has introduced the first legally binding standards for India’s cosmetology sector, a market currently valued at approximately $2.1 billion. These new regulations arrive as the government seeks to curb patient safety risks associated with the rapid proliferation of aesthetic clinics and the rise of so-called 'ghost clinics'—facilities where procedures are performed by untrained staff rather than licensed doctors.
Under the new guidelines, cosmetology clinics must be exclusively operated by registered dermatologists and plastic surgeons. Practitioners are now required to maintain clear disclosures regarding their qualifications and adhere to strict protocols for patient consent and medical record keeping. The government has also categorized cosmetic procedures into two levels based on complexity, with more invasive Level 2 treatments—such as ablative lasers—requiring specialized operating theatre infrastructure.
For investors and businesses operating in this space, the regulations introduce a new layer of operational complexity. While the move is intended to clean up the market, it creates potential margin pressure for clinics that currently rely on lower-cost, untrained technicians. Companies will likely need to increase spending on hiring qualified medical staff, upgrading facility infrastructure to meet safety standards, and ensuring compliance with biomedical waste management rules. This could lead to industry consolidation, where larger, organized players better equipped to absorb higher compliance costs may gain an advantage over smaller, unorganized clinics that struggle to adapt.
A critical area for stakeholders to track is the regulatory stance on injectables. The Central Drugs Standard Control Organisation (CDSCO) has clarified that many injectable products, such as dermal fillers, are classified as drugs or medical devices rather than cosmetics. This classification means they cannot be administered in standard beauty salons or wellness centers that lack medical registration. Businesses marketing aesthetic services must now navigate these stricter boundaries between beauty treatments and medical procedures, which carries potential legal and reputational liability if mismanaged.
The industry has generally welcomed the move, viewing it as a necessary step to build consumer trust and ensure long-term sustainability. However, the immediate impact on profitability will depend on how quickly firms can transition to these new staffing and facility requirements. Investors may track the pace of industry-wide compliance, any potential enforcement actions against non-compliant facilities by State Medical Councils, and management commentary from listed healthcare chains regarding the impact of these changes on their operational margins.